Canepa E, Parodi‐Rullan R, Vazquez‐Torres R, et al. FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness. Alzheimer's Dement. 2023;19:5048–5073. doi:10.1002/alz.13063.
We have identified an error in Figure 4, Panel 4E of the above article. Within the 20 representative pictures chosen to visualize the mean GFAP‐positive cell area, the image used as Tg + MTZ in the CA3 area was actually an image of a Tg mouse without treatment and the image used as Tg + MTZ in the RSC was actually an image of a Tg + ATZ. These 2 images were mistakenly chosen from the original folder when constructing the panel. This error had no effect on the quantification, which was performed independently, or on the data and conclusions of the article in any way.
FIGURE 4E.
For rigor, we have now replaced the images with the correct ones. Please find the new Panel 4E here.